To investigate the mechanisms underlying changes in CSF biomarkers in response to intrathecal mesenchymal stem cell-neural progenitor (MSC-NP) treatment in patients with progressive multiple sclerosis (MS).
No takes yet. Share an insight, caveat, or question.
Jagid et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: